AMBER MOORE: Open Payments
NPI 1396184222 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 126 payments from 19 companies in 2025. Trend: 2023 $2,198 · 2024 $2,347 · 2025 $2,022
Food & beverage: $2,022
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $377 |
| Novo Nordisk Inc | 22 | $336 |
| AstraZeneca Pharmaceuticals LP | 15 | $302 |
| Axsome Therapeutics, Inc. | 15 | $229 |
| ABBVIE INC. | 19 | $205 |
| Otsuka America Pharmaceutical, Inc. | 9 | $153 |
| PFIZER INC. | 11 | $144 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $35 |
Products named: CAPLYTA, REXULTI, Wegovy, Rybelsus, NURTEC ODT, BREZTRI, FARXIGA, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
